Gary Conrad
Cardiovascular Disease · Pasadena, CANPI 1669424271
Payments from drug & device makers
Across 189 payments — averaging $784.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kowa Research Institute, Inc.$132K
- Novartis$14K
- Amgen$525
- Pfizer$352
- Abbott$226
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$206
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,124100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kowa Research Institute, Inc. | 37 | $131,546 |
| Novartis | 33 | $14,002 |
| Amgen | 21 | $525 |
| Pfizer | 14 | $352 |
| Abbott | 12 | $226 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $206 |
| Johnson & Johnson | 12 | $197 |
| Amarin Pharma, Inc. | 3 | $181 |
| Bayer | 1 | $123 |
| Sanofi-aventis U.S. LLC | 5 | $104 |
| Medtronic | 1 | $100 |
| Esperion Therapeutics, Inc. | 4 | $97 |
| AstraZeneca | 4 | $68 |
| Akcea Therapeutics, Inc. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 4 | $57 |
| CMP Pharma, Inc. | 2 | $52 |
| Boehringer Ingelheim | 2 | $49 |
| Impulse Dynamics (USA) Inc. | 2 | $48 |
| Kowa Pharmaceuticals America, Inc. | 2 | $36 |
| Edwards Lifesciences | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Boston Scientific | 1 | $24 |
| Gilead | 1 | $20 |
| Philips North America LLC | 1 | $15 |
| Irhythm Technologies, Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $14 |
| Cleerly, Inc. | 1 | $13 |
| Travere Therapeutics, Inc. | 3 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerendia$123
- VYNDAQEL$121
- Vascepa$118
- Repatha$115
- Arctic Front$100
How this compares
$148,190 in reported general payments places this provider in the 90th percentile of 2,184 cardiovascular disease providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 20 | $309 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Pasadena
- Ted LoveHillsborough$102.8M
- Matthew BudoffTorrance$11.3M
- Lori DanielsSan Diego$10.2M
- Paul KurthSanta Barbara$6.1M
- Michael BlumSan Francisco$5.5M
- Tony ChouSan Francisco$5.2M
- Jason RogersSacramento$5.1M
- Yu-Ping WangStanford$3.8M
- Yogesh PaliwalPomona$3.3M
- Farhad RafiiWest Hills$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.